|
Report No. : |
307761 |
|
Report Date : |
18.02.2015 |
IDENTIFICATION DETAILS
|
Name : |
SIEMENS HEALTHCARE DIAGNOSTICS INC. |
|
|
|
|
Registered Office : |
511 Benedict Avenue, Tarrytown, NY 10591 |
|
|
|
|
Country : |
United States |
|
|
|
|
Date of Incorporation : |
29.12.1971 |
|
|
|
|
Legal Form : |
Corporation – Profit |
|
|
|
|
Line of Business : |
· The subsidiary of Siemens Healthcare offers a comprehensive array of diagnostic products, from in vitro diagnostic testing assays and to laboratory analysis instruments. · Subject also provides labs with information technology and consulting services. · Subject products ranges include RapidLab blood gas analyzers, ADVIA hematology and immunoassay systems, Dimension chemical laboratory automation systems, VERSANT molecular testing systems, DCA Vantage diabetes testing systems, and Viva drug testing systems. |
|
|
|
|
No of Employees : |
2,400 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
Payment Behaviour : |
Slow but Correct |
|
Litigation : |
Exists |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – December 31, 2014
|
Country Name |
Previous Rating (30.09.2014) |
Current Rating (31.12.2014) |
|
United States |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
United States ECONOMIC OVERVIEW
The US has the largest and most technologically
powerful economy in the world, with a per capita GDP of $49,800. In this
market-oriented economy, private individuals and business firms make most of
the decisions, and the federal and state governments buy needed goods and
services predominantly in the private marketplace. US business firms enjoy
greater flexibility than their counterparts in Western Europe and Japan in
decisions to expand capital plant, to lay off surplus workers, and to develop
new products. At the same time, they face higher barriers to enter their
rivals' home markets than foreign firms face entering US markets. US firms are
at or near the forefront in technological advances, especially in computers and
in medical, aerospace, and military equipment; their advantage has narrowed
since the end of World War II. The onrush of technology largely explains the
gradual development of a "two-tier labor market" in which those at
the bottom lack the education and the professional/technical skills of those at
the top and, more and more, fail to get comparable pay raises, health insurance
coverage, and other benefits. Since 1975, practically all the gains in
household income have gone to the top 20% of households. Since 1996, dividends
and capital gains have grown faster than wages or any other category of
after-tax income. Imported oil accounts for nearly 55% of US consumption. Crude
oil prices doubled between 2001 and 2006, the year home prices peaked; higher
gasoline prices ate into consumers' budgets and many individuals fell behind in
their mortgage payments. Oil prices climbed another 50% between 2006 and 2008,
and bank foreclosures more than doubled in the same period. Besides dampening
the housing market, soaring oil prices caused a drop in the value of the dollar
and a deterioration in the US merchandise trade deficit, which peaked at $840
billion in 2008. The sub-prime mortgage crisis, falling home prices, investment
bank failures, tight credit, and the global economic downturn pushed the United
States into a recession by mid-2008. GDP contracted until the third quarter of
2009, making this the deepest and longest downturn since the Great Depression.
To help stabilize financial markets, in October 2008 the US Congress
established a $700 billion Troubled Asset Relief Program (TARP). The government
used some of these funds to purchase equity in US banks and industrial
corporations, much of which had been returned to the government by early 2011.
In January 2009 the US Congress passed and President Barack OBAMA signed a bill
providing an additional $787 billion fiscal stimulus to be used over 10 years -
two-thirds on additional spending and one-third on tax cuts - to create jobs
and to help the economy recover. In 2010 and 2011, the federal budget deficit
reached nearly 9% of GDP. In 2012 the federal government reduced the growth of
spending and the deficit shrank to 7.6% of GDP. Wars in Iraq and Afghanistan
required major shifts in national resources from civilian to military purposes
and contributed to the growth of the budget deficit and public debt. Through
2011, the direct costs of the wars totaled nearly $900 billion, according to US
government figures. US revenues from taxes and other sources are lower, as a
percentage of GDP, than those of most other countries. In March 2010, President
OBAMA signed into law the Patient Protection and Affordable Care Act, a health
insurance reform that was designed to extend coverage to an additional 32
million American citizens by 2016, through private health insurance for the
general population and Medicaid for the impoverished. Total spending on health
care - public plus private - rose from 9.0% of GDP in 1980 to 17.9% in 2010. In
July 2010, the president signed the DODD-FRANK Wall Street Reform and Consumer
Protection Act, a law designed to promote financial stability by protecting
consumers from financial abuses, ending taxpayer bailouts of financial firms,
dealing with troubled banks that are "too big to fail," and improving
accountability and transparency in the financial system - in particular, by
requiring certain financial derivatives to be traded in markets that are
subject to government regulation and oversight. In December 2012, the Federal
Reserve Board (Fed) announced plans to purchase $85 billion per month of
mortgage-backed and Treasury securities in an effort to hold down long-term
interest rates, and to keep short term rates near zero until unemployment drops
below 6.5% or inflation rises above 2.5%. In late 2013, the Fed announced that
it would begin scaling back long-term bond purchases to $75 billion per month
in January 2014 and reduce them further as conditions warranted; the Fed,
however, would keep short-term rates near zero so long as unemployment and
inflation had not crossed the previously stated thresholds. Long-term problems
include stagnation of wages for lower-income families, inadequate investment in
deteriorating infrastructure, rapidly rising medical and pension costs of an
aging population, energy shortages, and sizable current account and budget
deficits.
|
Source : CIA |
Company name: SIEMENS HEALTHCARE DIAGNOSTICS INC.
Address: 511 Benedict Avenue, Tarrytown, NY
10591 - USA
Telephone: +1
914-531-8000
Website: www.medical-siemens.com
Corporate ID#: C0642223
State: California
Judicial form: Corporation – Profit
Date incorporated: 12-29-1971
Name of manager: Michael
REITERMANN
Business:
Siemens Healthcare Diagnostics can tell you what your problem is.
The subsidiary of Siemens Healthcare offers a comprehensive array of diagnostic products, from in vitro diagnostic testing assays and to laboratory analysis instruments.
Siemens Healthcare Diagnostics' lead products include RapidLab blood gas analyzers, ADVIA hematology and immunoassay systems, Dimension chemical laboratory automation systems, VERSANT molecular testing systems, DCA Vantage diabetes testing systems, and Viva drug testing systems.
Its products are sold globally through direct sales forces and through distribution agreements.
Siemens Healthcare Diagnostics also provides labs with information technology and consulting services.
Siemens Healthcare Diagnostics serves about 30,000 customers in some 120 countries. It has direct operations in France, Germany, Italy, Japan, Korea, the Netherlands, Poland, Spain, the UK, and the US.
Office of the Foreign Assets Control (OFAC):
· The company is not listed on the OFAC list.
· The Specially Designated Nationals (SDN) List is a publication of OFAC which lists individuals and organizations with whom United States citizens and permanent residents are prohibited from doing business.
No name of foreign suppliers available.
EIN: -
Staff: 2,400
Operations & branches:
At the headquarters, we
find the corporate office.
The Company maintains several branches in the
U.S. including:
3400 Middlebury Street
Elkhart, IN 46515
3850 Quadrangle Blvd
Orlando, FL 32817
and others.
Shareholders:
SIEMENS CORPORATION
170 Wood Avenue South
Iselin, NJ 08830
Management:
Michael REITERMANN is the President and CEO.
He has been Member of Executive Management for Healthcare Business at
Siemens Aktiengesellschaft since February 2015.
Mr. Reitermann served as the Chief Executive Officer of Diagnostics
Division of Siemens Aktiengesellschaft and Siemens Medical Solutions USA, Inc.
Mr. Reitermann served as the Chief Executive Officer at Siemens
Healthcare Diagnostics, Inc. since April 30, 2010.
He served as the Chief Executive Officer of Siemens Healthcare
Diagnostics Limited since April 30, 2010. He served as the Chief Executive
Officer of U S at Siemens Healthcare since July 2009 and was responsible for
sales, marketing, service and logistics across the Siemens Healthcare
portfolio, including medical imaging equipment, healthcare information
technology, and medical therapy. Mr. Reitermann served as President of Medical
Solutions Nuclear Medicine Group of Siemens Medical Solutions USA, Inc. since
July 2002. He served as the Chief Executive Officer of Siemens Molecular
Imaging Business Unit and the former Nuclear Medicine Division at Siemens
Medical Solutions.
He was responsible for the establishment and implementation of the
Molecular Imaging Division's business objectives around the world, as well as
the Division's overall financial performance. He served as Vice President for
Sales and Marketing of Angiography and X-ray Division (AX) at Siemens.
In this position, he was responsible for the worldwide marketing and
promotion of Siemens AX products, including the successful AXIOM product line.
From 1996 to 1998, he was a Partner in Siemens Management Consulting,
conducting consulting projects in the areas of benchmarking, strategy and
productivity. Prior to 1996, he served as a Consultant, then a Senior Project
Manager at the corporate strategies division of Siemens Corporate Planning and
Development. He serves as a Member of Board of Governors at National Electrical
Manufacturers Association. Mr. Reitermann was educated at
Hans-Grueninger-Gymnasium in Markgroeningen, Germany. He received a graduate
degree in Industrial Engineering from the University of Karlsruhe, Germany, and
a Master's of Business Administration from the University of British Columbia,
Canada.
Wolfgang WRUMNIG is the CFO.
In United States, privately
held corporations are not required to publish any financials.
On a direct call, a
financial assistant controlled the present report.
Sales declared for year
2014 is in the range of USD 150,000,000=
The business is said to be
profitable.
Banks: Wells Fargo Bank
Legal filings
& complaints:
State: Texas
Case number: 10-36675
Bankrupt Company: Quality Infusion Care,
Inc.
Case type: bk Chapter: 7 Asset: Yes Vol: v Judge: Jeff Bohm
Date filed: 08/03/2010
Date of last filing: 02/12/2015
State: South Dakota
Case number: 5:13-cv-05057-JLV
Plaintiff: Farrell Cherry
Defendant: SIEMENS HEALTHCARE DIAGNOSTICS
INC.
Jeffrey L. Viken, presiding
Date filed: 08/01/2013
Date of last filing: 07/21/2014
Cause: Job discrimination
State: Delaware
Case number: 1:12-cv-00505-LPS
Plaintiff: Enzo Life Sciences Inc.
Defendant: Siemens Healthcare Diagnostics
Inc.
Leonard P. Stark, presiding
Date filed: 04/20/2012
Date of last filing: 02/11/2015
Secured debts summary (UCC):
None